Controlled release of GDNF reduces nerve root-mediated behavioral hypersensitivity

Journal of Orthopaedic Research

Volumn 27, Issue 1, 2009, Pages 120-127

  Hubbard, Raymond D ^a   Martínez, Joan J ^a   Burdick, Jason A ^a   Winkelstein, Beth A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Allodynia; GDNF; Hydrogel; Neurotrophic factor; Radiculopathy

Indexed keywords

ETHYLENE GLYCOL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CONTROL GROUP; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HYDROGEL; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; NERVE ROOT COMPRESSION; NERVE ROOT INJURY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL ASSAY; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HYDROGEL; HYDROGELS; MALE; NERVE GROWTH FACTORS; NEURONS; PERIPHERAL NERVES; RATS; STRESS, MECHANICAL; TIME FACTORS;

EID: 58149236685     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20710     Document Type: Article

References (51)

1. Côté P, Cassidy JD, Carroll L. 2000. The factors associated with neck pain and its related disability in the Saskatchewan population. Spine 25:1109-1117.
2. Freeman MD, Croft AC, Rossignol AM, et al. 1999. A review and methodologic critique of the literature refuting whiplash syndrome. Spine 24:86-96.
3. Carter JW, Mirza SK, Tencer AF, et al. 2000. Canal geometry changes associated with axial compressive cervical spine fracture. Spine 25:46-54.
4. Torg JS, Guille JT, Jaffe S. 2002. Injuries to the cervical spine in American football players. J Bone Joint Surg [Am] 84:112-122.
5. Nuckley DJ, Konodi MA, Raynak GC, et al. 2002. Neural space integrity of the lower cervical spine: effect of normal range of motion. Spine 27:587-595.
6. Colburn RW, Rickman AJ, DeLeo JA. 1999. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157:289-304.
7. Winkelstein BA, Rutkowski MD, Sweitzer SM, et al. 2001. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol 439:127-139.
8. Hubbard RD, Winkelstein BA. 2005. Transient cervical nerve root compression in the rat induces bilateral forepaw allodynia and spinal glial activation: mechanical factors in painful neck injuries. Spine 30:1924-1932.
9. Rothman SM, Kreider RA, Winkelstein BA. 2005. Spinal neuropeptide responses in persistent and transient pain following cervical nerve root injury. Spine 30:2491-2496.
10. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, et al. 2001. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 17:306-315.
11. Kobayashi S, Yoshizawa H, Hachiya Y, et al. 1993. Vasogenic edema induced by compression injury to the spinal nerve root. Distribution of intravenously injected protein tracers and gadolinium-enhanced magnetic resonance imaging. Spine 18:1410-1424.
12. Kobayashi S, Yoshizawa H. 2002. Effect of mechanical compression on the vascular permeability of the dorsal root ganglion. J Orthop Res 20:730-739.
13. Watkins LR, Maier SF, Goehler LE. 1995. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289-302.
14. Igarashi T, Yabuki S, Kikuchi S, et al. 2005. Effect of acute nerve root compression on endoneurial fluid pressure and blood flow in rat dorsal root ganglia. J Orthop Res 23:420- 424.
15. Hubbard RD, Chen Z, Winkelstein BA. 2008. Transient cervical nerve root compression modulates pain: load thresholds for allodynia and sustained changes in spinal neuropeptide expression. J Biomech 41:677-685.
16. Ma C, LaMotte RH. 2007. Multiple sites for generation of ectopic spontaneous activity in neurons of the chronically compressed dorsal root ganglion. J Neurosci 27:14059-14068.
17. Wehling P, Cleveland SJ, Heininger K, et al. 1996. Neuro-physiologic changes in lumbar nerve root inflammation in the rat after treatment with cytokine inhibitors. Evidence for a role of interleukin-1. Spine 21:931-935.
18. Boucher TJ, Okuse K, Bennett DL, et al. 2000. Potent analgesic effects of GDNF in neuropathic pain states. Science 290:124-127.
19. Boucher T, McMahon S. 2001. Neurotrophic factors & neuropathic pain. Curr Opin Pharmacol 1:66-72.
20. Airaksinen MS, Saarma M. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
21. Ma W, Eisenach JC. 2002. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 15:1037-1047.
22. Wang R, Guo W, Ossipov MH, et al. 2003. Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain. Neuro-science 121:815-824.
23. Jang J, Nam T, Paik K, et al. 2004. Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neurosci Lett 360:129-132.
24. Bennett DL, Michael GJ, Ramachandran N, et al. 1998. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 18:3059-3072.
25. Nakamura S, Myers RR. 1999. Myelinated afferents sprout into lamina II of L3-5dorsal horn following chronic constriction nerve injury in rats. Brain Res 818:285-290.
26. Malcangio M, Getting SJ, Grist J, et al. 2002. A novel control mechanism based on GDNF modulation of somatostatin release from sensory neurones. FASEB J 16:730-732.
27. Takahashi N, Nagano M, Suzuki H, et al. 2003. Expression changes of glial cell line-derived neurotrophic factor in a rat model of neuropathic pain. J Med Dent Sci 50:87-92.
28. ten Bokum AM, Hofland LJ, van Hagen PM. 2000. Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw 11:161-176.
29. Bennett DL, Boucher TJ, Armanini MP, et al. 2000. The glial cell line-derived neurotrophic factor family receptor components are differentially regulated within sensory neurons after nerve injury. J Neurosci 20:427-437.
30. Lu P, Yang H, Jones LL, et al. 2004. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 24:6402-6409.
31. Zhou L, Baumgartner BJ, Hill-Felberg SJ, et al. 2003. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci 23:1424-1431.
32. Anseth KS, Metters AT, Bryant SJ, et al. 2002. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Controlled Release 78:199-209.
33. Goraltchouk A, Scanga V, Morshead CM, et al. 2006. Incorporation of protein-eluting micospheres into biodegradable nerve guidance channels for controlled release. J Controlled Release 110:400-407.
34. Nomura H, Katayama Y, Shoichet MS, et al. 2006. Complete spinal cord transection treated by implantation of a reinforced synthetic hydrogel channel results in syringomyelia and caudal migration of the rostral stump. Neurosurgery 59:183- 192.
35. Piantino J, Burdick JA, Goldberg D, et al. 2006. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol 201:359-367.
36. Sawhney A, Pathak C, Hubbell J. 1993. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly (alpha-hydroxy acid) diacrylate macromers. Macromolecules 26:581-587.
37. West JL, Hubbell JA. 1995. Photopolymerized hydrogel materials for drug-delivery applications. Reactive Polymers 25:139-147.
38. Burdick JA, Ward M, Liang E, et al. 2006. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials 27:452-459.
39. Lee AC, Yu VM, Lowe JB, et al. 2003. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol 184:295-303.
40. Taylor S, McDonald J, Sakiyama-Elbert S. 2004. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release 98:281-294.
41. Taylor S, Rosenzweig E, McDonald J, et al. 2006. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release 113:226-235.
42. Hubbard RD, Winkelstein BA. 2008. Nerve root compression produces axonal degeneration dependent on biomechanical thresholds for mechanical allodynia. Exp Neurol (in press).
43. Pong K, Xu RY, Beck KD, et al. 1997. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons. J Neurochem 69:986-994.
44. Pozas E, Ibanez CF. 2005. GDNF and GFR alphal promote differentiation and tangential migration of cortical GAB-Aergic neurons. Neuron 45:701-713.
45. Park S, Hong YW. 2006. Transcriptional regulation of artemin is related to neurite outgrowth and actin polymerization in mature DRG neurons. Neurosci Lett 404:61-66.
46. Ramer MS, Priestley JV, McMahon SB. 2000. Functional regeneration of sensory axons into the adult spinal cord. Nature 403:312-316.
47. Sajadi A, Bensadoun JC, Schneider BL, et al. 2006. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of 50. Parkinson disease. Neurobiol Dis 22:119-129.
48. O'Malley BW Jr, Ledley FD. 1993. Somatic gene therapy. Methods for the present and future. Arch Otolaryngol Head Neck Surg 119:1100-1107. 51.
49. Boyd RB, Hovland DN. 2004. Intraputamenal infusion of r-met HUGDNF for the treatment of Parkinson's disease. Gordon Research Conferences-Barriers of the CNS, Tilton, NH, June 27 My 2.
50. Xu XM, Guenard V, Kleitman N, et al. 1995. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 134:261-272.
51. Averill S, Michael GJ, Shortland PJ, et al. 2004. NGF and GDNF ameliorate the increase in ATF3 expression which occurs in dorsal root ganglion cells in response to peripheral nerve injury. Eur J Neurosci 19:1437-1445.